It's the sixth leading cause of death in the United States, with no existing cure. But these researchers are committed to finding better ways to diagnose, treat and prevent the debilitating disease, using everything from innovative biomarker tracking to a potential vaccine for early stage patients.
The 40,000-square-foot incubator is Johnson & Johnson Innovation's first international site—and it's located in a city primed to become the next nexus of great breakthroughs.